检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
机构地区:[1]安徽省蚌埠医学院第一附属医院,安徽蚌埠233004
出 处:《心血管病防治知识(学术版)》2013年第12期145-147,共3页Prevention and Treatment of Cardiovascular Disease
基 金:国家自然科学基金;编号:81170046
摘 要:肺动脉高压是一种肺血流受限引起肺血管阻力和压力持续性增高,最终导致右心衰竭甚至死亡的综合征,病理生理学的改变主要为肺血管收缩、重塑及原位血栓的形成。近年研究表明,钾离子通道决定着肺动脉平滑肌细胞膜上的膜静息电位形成、调节血管紧张性及参与肺动脉平滑肌细胞的生长、增殖和凋亡。因此,钾通道调节血管收缩和调控肺动脉平滑肌细胞(Pulmonary artery smooth muscle cells,PASMCs)凋亡等方面发挥重要作用,具有抗肺动脉高压的作用,有望成为治疗肺动脉高压的新靶点[1]。Pulmonary hypertension is a syndrome where pulmonary vascular resistance and pressure increase continuously due to limited pulmonary blood flow, eventually leading to right heart failure and even death. Pathophysiological changes mainly include pulmonary vasoconstriction, remodeling, and in situ thrombosis. In recent years, studies have shown that potassium channels determine the resting potential of pulmonary artery smooth muscle cells (PASMCs), regulate vascular tone, and are involved in the growth, proliferation, and apoptosis of PASMCs. Opening of potassium channels can inhibit vasoconstriction and induce apoptosis of PASMCs, thus reversing pulmonary hypertension. Therefore, potassium channel is expected to become a new target for the treatment of pulmonary hypertension.
关 键 词:电压门控性钾通道 肺动脉高压 增殖 凋亡 血管收缩
分 类 号:R543.2[医药卫生—心血管疾病]
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.147